Hikma Pharmaceuticals PLC carries a market capitalization of 3.28B, placing it among publicly traded companies globally.
| Market Cap | 3.28B |
| Enterprise Value | N/A |
Hikma Pharmaceuticals PLC's stock has declined approximately -21.40333% over the past 52 weeks. The 50-day moving average sits at 1,459.48, while the 200-day moving average is 1,510.86.
| Beta (5Y) | N/A |
| 52-Week Price Change | -21.40333% |
| 50-Day Moving Average | 1,459.48 |
| 200-Day Moving Average | 1,510.86 |
| Average Volume (20 Days) | N/A |